Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Everolimus × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Carcinoma, Renal Cell 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 4 Tuberous Sclerosis 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thymus Neoplasms 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Pheochromocytoma 1 Phase IB 1 Paraganglioma 1 Ovarian Neoplasms 1 Nevus 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphoma 1

Interventions

Paclitaxel 5 Bevacizumab 5 Carboplatin 4 mirvetuximab soravtansine 3 pembrolizumab 2 olaparib 2 liposomal doxorubicin 2 Hyperthermic Intraperitoneal Chemotherapy 2 trastuzumab deruxtecan 1 rucaparib 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 niraparib 1 isoquercitrin 1 fludarabine phosphate 1 fludarabine 1 cemiplimab 1 Topotecan 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Pharmaceutical Preparations 1 Nutrition Assessment 1 Nivolumab 1 Neoadjuvant Therapy 1 Injections 1 Immunotherapy, Adoptive 1 Glucose 1 GEN-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡